BackHorizon Therapeutics Plc Overview

Horizon Therapeutics Plc Cost of Revenue

Cost of Revenue analysis for HZNP.

Quarterly Cost of Revenue

$219.96M
↓ 4.46% YoY

As of Jun 30, 2023

Annual Cost of Revenue (TTM)

$903.44M
↓ 3.73% YoY

Trailing 12 months ending Jun 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin